Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
Final Subject Meets Enrollment Criteria and is Scheduled for Mid-June Treatment, More Than One Month Ahead of Original Target Final Subject Meets Enrollment Criteria and is Scheduled for Mid-June Trea
AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
08:47am, Wednesday, 27'th May 2026
Previously published Biosafety Level 4 pre-clinical study showed 100% survival with early treatment following infection in a mouse model following lethal doses of Ebola
Creo Medical Group to raise £5.5m and advance partial divestment
02:49am, Friday, 22'nd May 2026
Creo Medical Group PLC (AIM:CREO, FRA:1RC, OTC:CMEOF) announced plans to raise approximately £5.5 million through a placing as the medical device company moves to strengthen its balance sheet while
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
03:02pm, Wednesday, 20'th May 2026
OCALA, Fla. , May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company", today announced that it has entered into definitive agreements for a registered direct
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
03:02pm, Wednesday, 20'th May 2026
OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registere
88 Energy says Augusta-1 exploration well is on track for Q1 2027
02:35am, Wednesday, 20'th May 2026
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) has told investors that its planned Augusta-1 exploration well at South Prudhoe on Alaska's North Slope remains on track for a first-quarter 202
CMMI Institute Completes Pilot for New AI Maturity (AIM) Framework
11:41am, Tuesday, 19'th May 2026
SCHAUMBURG, Ill.--(BUSINESS WIRE)-- #isaca--CMMI Institute, a global leader in helping organizations reduce risk, boost performance, and build capability, is now extending this guidance to artificial
Increase in stockholder equity and note extension strengthen Company's ability to advance pancreatic cancer development strategy Increase in stockholder equity and note extension strengthen Company's
Europa Oil & Gas drops as North Yorkshire refuses planning for potential gas drilling
03:56am, Monday, 18'th May 2026
Europa Oil & Gas (Holdings) Plc (AIM:EOG, FRA:EGN) shares fell 8.3% to 1.33p after North Yorkshire Council refused planning permission for the Cloughton gas appraisal well in North Yorkshire. The AIM-
Sintana Energy raises $11.5m to support exploration plans in Namibia
03:09am, Monday, 18'th May 2026
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) has conditionally raised US$11.5 million to back a busy exploration programme, including drilling on the Chevron-operated Nabba-1 well in
CelLBxHealth strikes US clinical collaboration with AdventHealth cancer studies
02:39am, Monday, 18'th May 2026
CelLBxHealth PLC (AIM:CLBX, FRA:DWV), the AIM-listed circulating tumour cell (CTC) diagnostics company, has secured a collaboration with AdventHealth, one of the largest faith-based health systems in
Union Jack Oil says Crossroads well drilled on-budget, production testing due to start in June
02:49am, Friday, 15'th May 2026
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) told investors that its Crossroads well in Garvin County, Oklahoma, has been drilled on budget to a target depth of 4,600 feet, with evaluation an
AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
08:41am, Thursday, 14'th May 2026
Positive Data from Named Patient Program and Positive Interim Data from Ongoing Phase 2 Clinical Trial Segment featuring Professor Doctor Casper H.J. van Eijck, Professor and Pancreato-biliary Sur
OptiBiotix shares surge 13.5% as company plans SweetBiotix showcase for investors
05:32am, Thursday, 14'th May 2026
OptiBiotix Health PLC (AIM:OPTI, OTCQB:OPTBF), the AIM-listed life sciences company developing gut microbiome products and healthy sugar substitutes, saw its shares jump 13.5% to 5.68p after announcin
Aimia Inc. (AIM:CA) Shareholder/Analyst Call Transcript
02:40pm, Wednesday, 13'th May 2026
Aimia Inc. (AIM:CA) Shareholder/Analyst Call Transcript
